Literature DB >> 25147375

How to treat old MCL patients: one size fits it all?

Martin Dreyling1, Simone Ferrero2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25147375      PMCID： PMC4141505          DOI： 10.1182/blood-2014-06-578872

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.

Authors:  Eva Hoster; Wolfram Klapper; Olivier Hermine; Hanneke C Kluin-Nelemans; Jan Walewski; Achiel van Hoof; Marek Trneny; Christian H Geisler; Francesco Di Raimondo; Michal Szymczyk; Stephan Stilgenbauer; Catherine Thieblemont; Michael Hallek; Roswitha Forstpointner; Christiane Pott; Vincent Ribrag; Jeanette Doorduijn; Wolfgang Hiddemann; Martin H Dreyling; Michael Unterhalt
Journal:  J Clin Oncol       Date:  2014-03-31       Impact factor: 44.544

2.  Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.

Authors:  Anna Abrahamsson; Alexandra Albertsson-Lindblad; Peter N Brown; Stefanie Baumgartner-Wennerholm; Lars M Pedersen; Francesco D'Amore; Herman Nilsson-Ehle; Paw Jensen; Michael Pedersen; Christian H Geisler; Mats Jerkeman
Journal:  Blood       Date:  2014-05-23       Impact factor: 22.113

3.  Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.

Authors:  Mathias J Rummel; Norbert Niederle; Georg Maschmeyer; G Andre Banat; Ulrich von Grünhagen; Christoph Losem; Dorothea Kofahl-Krause; Gerhard Heil; Manfred Welslau; Christina Balser; Ulrich Kaiser; Eckhart Weidmann; Heinz Dürk; Harald Ballo; Martina Stauch; Fritz Roller; Juergen Barth; Dieter Hoelzer; Axel Hinke; Wolfram Brugger
Journal:  Lancet       Date:  2013-02-20       Impact factor: 79.321

Review 4.  Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.

Authors:  Martin Dreyling; Hanneke C Kluin-Nelemans; Sílvia Beà; Wolfram Klapper; Niclas Vogt; Marie-Helene Delfau-Larue; Grit Hutter; Chan Cheah; Annalisa Chiappella; Sergio Cortelazzo; Christiane Pott; Georg Hess; Carlo Visco; Umberto Vitolo; Pavel Klener; Igor Aurer; Michael Unterhalt; Vincent Ribrag; Eva Hoster; Olivier Hermine
Journal:  Leuk Lymphoma       Date:  2012-11-21

5.  Treatment of older patients with mantle-cell lymphoma.

Authors:  H C Kluin-Nelemans; E Hoster; O Hermine; J Walewski; M Trneny; C H Geisler; S Stilgenbauer; C Thieblemont; U Vehling-Kaiser; J K Doorduijn; B Coiffier; R Forstpointner; H Tilly; L Kanz; P Feugier; M Szymczyk; M Hallek; S Kremers; G Lepeu; L Sanhes; J M Zijlstra; R Bouabdallah; P J Lugtenburg; M Macro; M Pfreundschuh; V Procházka; F Di Raimondo; V Ribrag; M Uppenkamp; M André; W Klapper; W Hiddemann; M Unterhalt; M H Dreyling
Journal:  N Engl J Med       Date:  2012-08-09       Impact factor: 91.245

6.  Outcome of deferred initial therapy in mantle-cell lymphoma.

Authors:  Peter Martin; Amy Chadburn; Paul Christos; Karen Weil; Richard R Furman; Jia Ruan; Rebecca Elstrom; Ruben Niesvizky; Scott Ely; Maurizio Diliberto; Ari Melnick; Daniel M Knowles; Selina Chen-Kiang; Morton Coleman; John P Leonard
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

Review 7.  New paradigms for treating elderly patients with cancer: the comprehensive geriatric assessment and guidelines for supportive care.

Authors:  Lodovico Balducci
Journal:  J Support Oncol       Date:  2003 Nov-Dec

8.  Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.

Authors:  Michael L Wang; Simon Rule; Peter Martin; Andre Goy; Rebecca Auer; Brad S Kahl; Wojciech Jurczak; Ranjana H Advani; Jorge E Romaguera; Michael E Williams; Jacqueline C Barrientos; Ewa Chmielowska; John Radford; Stephan Stilgenbauer; Martin Dreyling; Wieslaw Wiktor Jedrzejczak; Peter Johnson; Stephen E Spurgeon; Lei Li; Liang Zhang; Kate Newberry; Zhishuo Ou; Nancy Cheng; Bingliang Fang; Jesse McGreivy; Fong Clow; Joseph J Buggy; Betty Y Chang; Darrin M Beaupre; Lori A Kunkel; Kristie A Blum
Journal:  N Engl J Med       Date:  2013-06-19       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.